Assessment of pathological features in Alzheimer’s disease brain tissue with a large field-of-view visible-light optical coherence microscope
暂无分享,去创建一个
Marco Augustin | Bernhard Baumann | Christoph K Hitzenberger | Antonia Lichtenegger | Danielle J. Harper | Pablo Eugui | Adelheid Woehrer | Martina Muck | Danielle J Harper | Konrad Leskovar | C. Hitzenberger | B. Baumann | A. Woehrer | Antonia Lichtenegger | Marco Augustin | Pablo Eugui | Martina Muck | Konrad Leskovar
[1] Frank M LaFerla,et al. Animal models of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[2] Yan Wang,et al. Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice , 2009, The Journal of Neuroscience.
[3] Qi Wang,et al. Application of APP/PS1 Transgenic Mouse Model for Alzheimer Disease , 2015 .
[4] Ji Yi,et al. Visible-Light Optical Coherence Tomography Angiography for Monitoring Laser-Induced Choroidal Neovascularization in Mice , 2016, Investigative ophthalmology & visual science.
[5] Stefan Platzer,et al. Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease , 2012, PloS one.
[6] V. Srinivasan,et al. Optical coherence microscopy for deep tissue imaging of the cerebral cortex with intrinsic contrast , 2012, Optics express.
[7] J. Hardy,et al. The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.
[8] J. Fujimoto,et al. Speckle reduction in optical coherence tomography images by use of a spatially adaptive wavelet filter. , 2004, Optics letters.
[9] E. McVeigh,et al. Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography , 2015, Science Translational Medicine.
[10] Shau Poh Chong,et al. Visible light optical coherence microscopy of the brain with isotropic femtoliter resolution in vivo. , 2018, Optics letters.
[11] Christoph K. Hitzenberger,et al. Beyond backscattering: optical neuroimaging by BRAD , 2017, Biomedical optics express.
[12] Jeff W. Lichtman,et al. Clarifying Tissue Clearing , 2015, Cell.
[13] C. Jack,et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria , 2016, Alzheimer's & Dementia.
[14] Pei-Lin Hsiung,et al. Effect of tissue preservation on imaging using ultrahigh resolution optical coherence tomography. , 2005, Journal of biomedical optics.
[15] Ji Yi,et al. In vivo functional microangiography by visible-light optical coherence tomography. , 2014, Biomedical optics express.
[16] Theo Lasser,et al. Visible spectrum extended-focus optical coherence microscopy for label-free sub-cellular tomography. , 2017, Biomedical optics express.
[17] Brett E. Bouma,et al. Label-free volumetric optical imaging of intact murine brains , 2017, Scientific Reports.
[18] Qing X Yang,et al. MRI and histological analysis of beta‐amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice , 2009, Journal of magnetic resonance imaging : JMRI.
[19] Brian J. Bacskai,et al. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy , 2001, Nature Medicine.
[20] M. Tomonaga,et al. Cerebral Amyloid Angiopathy in the Elderly , 1981, Journal of the American Geriatrics Society.
[21] D. Borchelt,et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. , 2001, Biomolecular engineering.
[22] Gary F. Egan,et al. A review of β-amyloid neuroimaging in Alzheimer's disease , 2014, Front. Neurosci..
[23] Martin Wasser,et al. Effects of Hydrogen Peroxide on Wound Healing in Mice in Relation to Oxidative Damage , 2012, PloS one.
[24] Sage C. Arbor,et al. Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores , 2016, The Yale journal of biology and medicine.
[25] Kwanghun Chung,et al. Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems , 2015, Cell.
[26] Allan R. Jones,et al. Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.
[27] Ryan Chamberlain,et al. Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease. , 2011, Current medical imaging reviews.
[28] J. C. Lodder,et al. Volumetric Imaging and Quantification of Cytoarchitecture and Myeloarchitecture with Intrinsic Scattering Contrast References and Links , 2022 .
[29] Sebastian Munck,et al. Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer’s disease mouse models , 2015, Science Translational Medicine.
[30] Marc Flajolet,et al. Three-Dimensional Study of Alzheimer's Disease Hallmarks Using the iDISCO Clearing Method. , 2016, Cell reports.
[31] David A Boas,et al. Characterizing the optical properties of human brain tissue with high numerical aperture optical coherence tomography. , 2017, Biomedical optics express.
[32] Eric L. Miller,et al. Hybrid FMT–CT imaging of amyloid-β plaques in a murine Alzheimer's disease model , 2009, NeuroImage.
[33] Shuliang Jiao,et al. Visible-light optical coherence tomography-based multimodal retinal imaging for improvement of fluorescent intensity quantification. , 2016, Biomedical optics express.
[34] A. Fercher,et al. Performance of fourier domain vs. time domain optical coherence tomography. , 2003, Optics express.
[35] Christoph K. Hitzenberger,et al. Spectroscopic imaging with spectral domain visible light optical coherence microscopy in Alzheimer’s disease brain samples , 2017, Biomedical optics express.
[36] J. Vickers,et al. The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s disease , 2001, Neuroscience.
[37] B. Hyman,et al. Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.
[38] D. Westaway,et al. Transgenic mouse models of Alzheimer's disease , 2001, Physiology & Behavior.
[39] Frédéric Lesage,et al. Imaging whole mouse brains with a dual resolution serial swept-source optical coherence tomography scanner , 2018, BiOS.
[40] Theo Lasser,et al. In vivo high-resolution cortical imaging with extended-focus optical coherence microscopy in the visible-NIR wavelength range , 2018, Journal of biomedical optics.
[41] M. Staufenbiel,et al. Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* , 2001, The Journal of Biological Chemistry.
[42] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[43] Joanna L. Jankowsky,et al. Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .
[44] Michael Unser,et al. A pyramid approach to subpixel registration based on intensity , 1998, IEEE Trans. Image Process..
[45] Jie Luo,et al. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging , 2017, NeuroImage.
[46] Guido Gerig,et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.
[47] Hans-Ulrich Dodt,et al. Cerebral β-Amyloidosis in Mice Investigated by Ultramicroscopy , 2015, PloS one.
[48] Kirsten Schmieder,et al. Automated differentiation between meningioma and healthy brain tissue based on optical coherence tomography ex vivo images using texture features , 2018, Journal of biomedical optics.
[49] Ruopeng Wang,et al. Polarization sensitive optical coherence microscopy for brain imaging. , 2016, Optics letters.
[50] Marc Dhenain,et al. In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid Immunotherapy , 2016, Front. Aging Neurosci..
[51] M. Goubran,et al. Seven-Tesla MRI and neuroimaging biomarkers for Alzheimer's disease. , 2015, Neurosurgical focus.
[52] S. Gigan,et al. Brain refractive index measured in vivo with high-NA defocus-corrected full-field OCT and consequences for two-photon microscopy. , 2011, Optics express.
[53] Anna Medyukhina,et al. Fully Automated Evaluation of Total Glomerular Number and Capillary Tuft Size in Nephritic Kidneys Using Lightsheet Microscopy. , 2017, Journal of the American Society of Nephrology : JASN.
[54] Julien Rossignol,et al. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer’s disease mice , 2016, Histochemistry and Cell Biology.
[55] Christoph K. Hitzenberger,et al. Visualization of neuritic plaques in Alzheimer’s disease by polarization-sensitive optical coherence microscopy , 2017, Scientific Reports.
[56] Renu Tripathi,et al. Spectral shaping for non-Gaussian source spectra in optical coherence tomography. , 2002, Optics letters.
[57] R. Carare,et al. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease , 2009, Alzheimer's Research & Therapy.
[58] H. Lemij,et al. Depth-resolved model-based reconstruction of attenuation coefficients in optical coherence tomography. , 2013, Biomedical optics express.
[59] Qingming Luo,et al. Recent progress in tissue optical clearing , 2013, Laser & photonics reviews.
[60] M. Villiger,et al. Label-Free Imaging of Cerebral β-Amyloidosis with Extended-Focus Optical Coherence Microscopy , 2012, The Journal of Neuroscience.
[61] Semi Helin,et al. Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model , 2017, Neurobiology of Aging.
[62] B. Devaux,et al. Imaging of non-tumorous and tumorous human brain tissues with full-field optical coherence tomography☆ , 2013, NeuroImage: Clinical.